Yasmin Schmid

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study.

Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study.

Journal: BMJ open

Published: May 11, 2026

Effects of repeated low-dose LSD on neuropsychological functioning in adults with ADHD: a randomized placebo-controlled study.

Effects of repeated low-dose LSD on neuropsychological functioning in adults with ADHD: a randomized placebo-controlled study.

Journal: Psychopharmacology

Published: February 18, 2026

The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.

The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.

Journal: Journal of psychopharmacology (Oxford, England)

Published: December 26, 2025

Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances.

Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances.

Journal: Swiss medical weekly

Published: August 14, 2025

Psychedelic-Assisted Therapy in Palliative Care-Insights from an International Workshop.

Psychedelic-Assisted Therapy in Palliative Care-Insights from an International Workshop.

Journal: Healthcare (Basel, Switzerland)

Published: July 03, 2025

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants.

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants.

Journal: Clinical pharmacokinetics

Published: June 22, 2025

Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.

Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.

Journal: Neuroscience applied

Published: May 05, 2025

Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics.

Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics.

Journal: Frontiers in psychiatry

Published: March 26, 2025

Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial.

Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial.

Journal: JAMA psychiatry

Published: March 19, 2025

Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.

Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.

Journal: The Cochrane database of systematic reviews

Published: September 11, 2024

Safety pharmacology of acute mescaline administration in healthy participants.

Safety pharmacology of acute mescaline administration in healthy participants.

Journal: British journal of clinical pharmacology

Published: July 24, 2024

Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020.

Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: June 27, 2024

Showing 1-12 of 60

Last Updated: 09/26/2026